Qube Research & Technologies (QRT)
AEON icon

Qube Research & Technologies (QRT)’s AEON Biopharma AEON Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15
Closed -$1.11K – 3235
2024
Q2 		$1.11K Sell
15
-816
-98% -$194K ﹤0.01% 3252
2024
Q1 		$694K Buy
831
+776
+1,411% +$562K ﹤0.01% 2364
2023
Q4 		$28.3K Buy
+55
New +$22.1K ﹤0.01% 3430
2022
Q1 		– Sell
-235
Closed -$165K – 2393
2021
Q4 		$165K Buy
235
+83
+55% +$58.4K ﹤0.01% 2028
2021
Q3 		$107K Hold
152
– – ﹤0.01% 1784
2021
Q2 		$106K Buy
+152
New +$106K ﹤0.01% 1941

Other funds holding AEON

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AEON Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of AEON Biopharma (AEON) in Q3 2024, closing a stake of 15 shares — an estimated $1.11K sold.

Qube Research & Technologies (QRT) first reported a position in AEON in Q2 2021 and held it in 6 quarters. The position peaked at $694K in Q1 2024. 30 funds tracked by Wall St. Rank hold AEON as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining AEON Biopharma position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 15 AEON Biopharma shares in Q3 2024, an estimated $1.11K.
  • Qube Research & Technologies (QRT) first reported a position in AEON Biopharma in Q2 2021 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s AEON Biopharma position peaked at $694K in Q1 2024.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.